{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:23:39Z","timestamp":1790396619457,"version":"4.1.0"},"reference-count":209,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular disease (CVD) represents the leading cause of mortality and disability all over the world. Identifying new targeted therapeutic approaches has become a priority of biomedical research to improve patient outcomes and quality of life. The RAS-RAF-MEK (mitogen-activated protein kinase kinase)-ERK (extracellular signal-regulated kinase) pathway is gaining growing interest as a potential signaling cascade implicated in the pathogenesis of CVD. This pathway is pivotal in regulating cellular processes like proliferation, growth, migration, differentiation, and survival, which are vital in maintaining cardiovascular homeostasis. In addition, ERK signaling is involved in controlling angiogenesis, vascular tone, myocardial contractility, and oxidative stress. Dysregulation of this signaling cascade has been linked to cell dysfunction and vascular and cardiac pathological remodeling, which contribute to the onset and progression of CVD. Recent and ongoing research has provided insights into potential therapeutic interventions targeting the RAS-RAF-MEK-ERK pathway to improve cardiovascular pathologies. Preclinical studies have demonstrated the efficacy of targeted therapy with MEK inhibitors (MEKI) in attenuating ERK activation and mitigating CVD progression in animal models. In this article, we first describe how ERK signaling contributes to preserving cardiovascular health. We then summarize current knowledge of the roles played by ERK in the development and progression of cardiac and vascular disorders, including atherosclerosis, myocardial infarction, cardiac hypertrophy, heart failure, and aortic aneurysm. We finally report novel therapeutic strategies for these CVDs encompassing MEKI and discuss advantages, challenges, and future developments for MEKI therapeutics.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1404253","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T05:02:43Z","timestamp":1719810163000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["MEK inhibitors: a promising targeted therapy for cardiovascular disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Khaled A. K.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/biomedicines8120552","article-title":"Advances in cardiovascular biomarker discovery","volume":"8","author":"Ghantous","year":"2020","journal-title":"Biomedicines"},{"key":"B2","article-title":"Noncommunicable diseases country profiles 2018","year":"2018"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1520-037X.2002.00564.x","article-title":"Reducing the global burden of cardiovascular disease: the role of risk factors","volume":"5","author":"Levenson","year":"2002","journal-title":"Prev Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1573403X14666180222102312","article-title":"Management of measurable variable cardiovascular disease\u2019 risk factors","volume":"14","author":"Francula-Zaninovic","year":"2018","journal-title":"Curr Cardiol Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.31083\/j.rcm2301019","article-title":"Sex beyond cardiovascular risk factors and clinical biomarkers of cardiovascular disease","volume":"23","author":"Bergami","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch Toxicol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2404806","DOI":"10.1155\/2023\/2404806","article-title":"Shared lifestyle-related risk factors of cardiovascular disease and cancer: evidence for joint prevention","volume":"2023","author":"Masoudkabir","year":"2023","journal-title":"TheScientificWorldJournal"},{"key":"B9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/CIRCRESAHA.118.312563","article-title":"Mechanisms of dysfunction in the aging vasculature and role in age-related disease","volume":"123","author":"Donato","year":"2018","journal-title":"Circ Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.amepre.2017.08.005","article-title":"Conducting research on the economics of hypertension to improve cardiovascular health","volume":"53","author":"Wang","year":"2017","journal-title":"Am J Prev Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"623674","DOI":"10.3389\/fphar.2021.623674","article-title":"Targeted therapy in cardiovascular disease: a precision therapy era","volume":"12","author":"Xu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1093\/eurheartj\/ehaa229","article-title":"From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases","volume":"41","author":"Landmesser","year":"2020","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cphy.c140055","article-title":"Pathophysiology of heart failure","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.3390\/ijms20092164","article-title":"ERK: a key player in the pathophysiology of cardiac hypertrophy","volume":"20","author":"Gallo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/CIRCRESAHA.118.313187","article-title":"Cellular mechanisms of aortic aneurysm formation","volume":"124","author":"Quintana","year":"2019","journal-title":"Circ Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1202381","DOI":"10.3389\/fcvm.2023.1202381","article-title":"Application of next generation sequencing in cardiology: current and future precision medicine implications","volume":"10","author":"Papadopoulou","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0140-6736(20)30164-1","article-title":"Small molecules, big impact: 20 years of targeted therapy in oncology","volume":"395","author":"Bedard","year":"2020","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/neurolint12030016","article-title":"Ozanimod to treat relapsing forms of multiple sclerosis: a comprehensive review of disease, drug efficacy and side effects","volume":"12","author":"Lassiter","year":"2020","journal-title":"Neurol Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e022452","DOI":"10.1136\/bmjopen-2018-022452","article-title":"Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I\/II clinical trial","volume":"8","author":"Zhao","year":"2018","journal-title":"BMJ Open"},{"key":"B20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The RAS-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: from signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski R","year":"2012","journal-title":"Pharmacol Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"8881","DOI":"10.1073\/pnas.92.19.8881","article-title":"Association of mitogen-activated protein kinase with the microtubule cytoskeleton","volume":"92","author":"Reszka","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1042\/bj3440117","article-title":"Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins","volume":"344","author":"Leinweber","year":"1999","journal-title":"Biochem J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1083\/jcb.137.2.481","article-title":"Regulation of cell motility by mitogen-activated protein kinase","volume":"137","author":"Klemke","year":"1997","journal-title":"J Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.febslet.2004.06.003","article-title":"The phosphorylation status and anti-apoptotic activity of bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria","volume":"569","author":"Tamura","year":"2004","journal-title":"FEBS Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0092-8674(00)81189-7","article-title":"Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation","volume":"93","author":"Khokhlatchev","year":"1998","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm.1893","article-title":"A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy","volume":"15","author":"Lorenz","year":"2009","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41467-020-15505-4","article-title":"Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1\/2 signaling without cardiotoxic side-effects","volume":"11","author":"Tomasovic","year":"2020","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.12688\/wellcomeopenres.15091.2","article-title":"ELK1 has a dual activating and repressive role in human embryonic stem cells","volume":"4","author":"Prise","year":"2019","journal-title":"Wellcome Open Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.21037\/atm-20-6742","article-title":"Inhibition of sphingosine kinase 2 down-regulates ERK\/c-Myc pathway and reduces cell proliferation in human epithelial ovarian cancer","volume":"9","author":"Dai","year":"2021","journal-title":"Ann Transl Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.molcel.2008.07.024","article-title":"Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes","volume":"31","author":"Casar","year":"2008","journal-title":"Mol Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1074\/jbc.M109.064972","article-title":"ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation","volume":"285","author":"Lidke","year":"2010","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.4161\/cc.8.7.8078","article-title":"ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task","volume":"8","author":"Casar","year":"2009","journal-title":"Cell Cycle"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1128\/MCB.20.9.3079-3085.2000","article-title":"Mechanism of suppression of the Raf\/MEK\/extracellular signal-regulated kinase pathway by the Raf kinase inhibitor protein","volume":"20","author":"Yeung","year":"2000","journal-title":"Mol Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/43686","article-title":"Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP","volume":"401","author":"Yeung","year":"1999","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"25320","DOI":"10.1074\/jbc.270.43.25320","article-title":"Negative feedback regulation and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation","volume":"270","author":"Langlois","year":"1995","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/sj.onc.1201214","article-title":"EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2","volume":"15","author":"Douville","year":"1997","journal-title":"Oncogene"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3389\/fpls.2018.01697","article-title":"Central roles and regulatory mechanisms of dual-specificity MAPK phosphatases in developmental and stress signaling","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Plant Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1074\/jbc.275.10.6749","article-title":"Mechanistic basis for catalytic activation of mitogen-activated protein kinase phosphatase 3 by extracellular signal-regulated kinase","volume":"275","author":"Fjeld","year":"2000","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"31531","DOI":"10.18632\/oncotarget.25847","article-title":"The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation","volume":"9","author":"Schneider","year":"2018","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1097-2765(02)00519-1","article-title":"The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1\/2","volume":"9","author":"Lu","year":"2002","journal-title":"Mol Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1242\/jcs.036319","article-title":"Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway","volume":"122","author":"Shin","year":"2009","journal-title":"J Cell Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1242\/jcs.02505","article-title":"The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity","volume":"118","author":"Ebisuya","year":"2005","journal-title":"J Cell Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cellsig.2008.11.013","article-title":"Protein scaffolds in MAP kinase signalling","volume":"21","author":"Brown","year":"2009","journal-title":"Cell Signal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fcell.2016.00049","article-title":"ERK signals: scaffolding scaffolds?","volume":"4","author":"Casar","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1091\/mbc.e06-07-0659","article-title":"Nuclear localization of the ERK MAP kinase mediated by drosophila alphaPS2betaPS integrin and importin-7","volume":"18","author":"James","year":"2007","journal-title":"Mol Biol Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mce.2009.04.008","article-title":"The subcellular localization of MEK and ERK\u2013a novel nuclear translocation signal (NTS) paves a way to the nucleus","volume":"314","author":"Zehorai","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ccell.2015.07.001","article-title":"Small molecule inhibition of ERK dimerization prevents tumorigenesis by RAS-ERK pathway oncogenes","volume":"28","author":"Herrero","year":"2015","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1038\/ncomms7685","article-title":"The nuclear translocation of ERK1\/2 as an anticancer target","volume":"6","author":"Plotnikov","year":"2015","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"569955","DOI":"10.3389\/fphar.2020.569955","article-title":"Two targets, one hit: new anticancer therapeutics to prevent tumorigenesis without cardiotoxicity","volume":"11","author":"Szabo","year":"2020","journal-title":"Front Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s11030-020-10088-0","article-title":"Structure-activity relationship study of DEL-22379: ERK dimerization inhibitors with increased safety","volume":"25","author":"Yang","year":"2021","journal-title":"Mol Divers"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","article-title":"Signal transduction mediated by the Ras\/Raf\/MEK\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention","volume":"17","author":"Chang","year":"2003","journal-title":"Leukemia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.apsb.2021.12.022","article-title":"Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy","volume":"12","author":"Pan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B56","doi-asserted-by":"publisher","first-page":"102907","DOI":"10.1016\/j.jbc.2023.102907","article-title":"Inhibiting O-GlcNAcylation impacts p38 and Erk1\/2 signaling and perturbs cardiomyocyte hypertrophy","volume":"299","author":"Papanicolaou","year":"2023","journal-title":"J Biol Chem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","article-title":"MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo","volume":"109","author":"Lips","year":"2004","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"31246","DOI":"10.1074\/jbc.M806085200","article-title":"DUSP6 (MKP3) null mice show enhanced ERK1\/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility","volume":"283","author":"Maillet","year":"2008","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1\u2013ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fphar.2015.00149","article-title":"Extracellular signal-regulated kinases 1\/2 as regulators of cardiac hypertrophy","volume":"6","author":"Mutlak","year":"2015","journal-title":"Front Pharmacol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00018-023-05007-z","article-title":"Emerging roles and mechanisms of ERK pathway mechanosensing","volume":"80","author":"Crozet","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/112_2016_8","article-title":"The stress-response MAP kinase signaling in cardiac arrhythmias","volume":"172","author":"Ai","year":"2016","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/glycob\/cwp199","article-title":"A polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heart","volume":"20","author":"Wang","year":"2010","journal-title":"Glycobiology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e152308","DOI":"10.1172\/JCI152308","article-title":"Cardiac pericyte reprogramming by MEK inhibition promotes arteriologenesis and angiogenesis of the ischemic heart","volume":"132","author":"Avolio","year":"2022","journal-title":"J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/aps.2010.65","article-title":"Activation of the ERK signaling pathway is involved in CD151-induced angiogenic effects on the formation of CD151-integrin complexes","volume":"31","author":"Zuo","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1084\/jem.20182151","article-title":"Endothelial ERK1\/2 signaling maintains integrity of the quiescent endothelium","volume":"216","author":"Ricard","year":"2019","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/cm.20172","article-title":"MEK\/ERK regulates adherens junctions and migration through Rac1","volume":"64","author":"Ray","year":"2007","journal-title":"Cell Motil Cytoskeleton"},{"key":"B68","doi-asserted-by":"publisher","first-page":"20220587","DOI":"10.1515\/biol-2022-0587","article-title":"Shear stress leads to the dysfunction of endothelial cells through the cav-1-mediated KLF2\/eNOS\/ERK signaling pathway under physiological conditions","volume":"18","author":"Wang","year":"2023","journal-title":"Open Life Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"104346","DOI":"10.1016\/j.mvr.2022.104346","article-title":"Inhibition of semaphorin-3a alleviates lipopolysaccharide-induced vascular injury","volume":"142","author":"Fu","year":"2022","journal-title":"Microvasc Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2200908","DOI":"10.1080\/08916934.2023.2200908","article-title":"Sema3A inactivates the ERK\/JNK signalling pathways to alleviate inflammation and oxidative stress in lipopolysaccharide-stimulated rat endothelial cells and lung tissues","volume":"56","author":"Qiu","year":"2023","journal-title":"Autoimmunity"},{"key":"B71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0891-5849(03)00311-3","article-title":"Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells","volume":"35","author":"Oliveira","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yexcr.2016.07.019","article-title":"Nitric oxide and ERK mediates regulation of cellular processes by Ecdysterone","volume":"346","author":"Omanakuttan","year":"2016","journal-title":"Exp Cell Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.abb.2014.06.011","article-title":"Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis","volume":"558","author":"Moraes","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"B74","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41569-023-00913-y","article-title":"The role of cardiac pericytes in health and disease: therapeutic targets for myocardial infarction","volume":"21","author":"Avolio","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.HYP.0000054213.37471.84","article-title":"ERK1\/2-dependent contractile protein expression in vascular smooth muscle cells","volume":"41","author":"Schauwienold","year":"2003","journal-title":"Hypertension"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1161\/01.ATV.0000136548.17816.07","article-title":"Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1\/2 signaling pathway activation","volume":"24","author":"Kawai-Kowase","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1124\/pr.115.010652","article-title":"Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders","volume":"68","author":"Brozovich","year":"2016","journal-title":"Pharmacol Rev"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3892\/ijmm.2018.3673","article-title":"Inhibition of MEK\/ERK\/STAT3 signaling in oleuropein treatment inhibits myocardial ischemia\/reperfusion","volume":"42","author":"Jin","year":"2018","journal-title":"Int J Mol Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/00005344-200008000-00012","article-title":"Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium","volume":"36","author":"Strohm","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"H971","DOI":"10.1152\/ajpheart.00374.2004","article-title":"Ischemic preconditioning protects by activating prosurvival kinases at reperfusion","volume":"288","author":"Hausenloy","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/jcb.22498","article-title":"Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse","volume":"109","author":"Yeh","year":"2010","journal-title":"J Cell Biochem"},{"key":"B82","doi-asserted-by":"publisher","first-page":"479","DOI":"10.21037\/atm-21-503","article-title":"Constitutive activation of ERK1\/2 signaling protects against myocardial ischemia via inhibition of mitochondrial fragmentation in the aging heart","volume":"9","author":"Zhao","year":"2021","journal-title":"Ann Transl Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1164166","DOI":"10.3389\/fcell.2023.1164166","article-title":"The role of the ERK signaling pathway in promoting angiogenesis for treating ischemic diseases","volume":"11","author":"Song","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/01.CIR.0000074225.62168.68","article-title":"Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage","volume":"108","author":"Hayakawa","year":"2003","journal-title":"Circulation"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced angiogenesis: good and evil","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1573403X113099990003","article-title":"Cellular and pharmacological targets to induce coronary arteriogenesis","volume":"10","author":"Hollander","year":"2014","journal-title":"Curr Cardiol Rev"},{"key":"B87","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.atherosclerosis.2005.02.017","article-title":"JTT-705 blocks cell proliferation and angiogenesis through p38 kinase\/p27kip1 and Ras\/p21waf1 pathways","volume":"182","author":"Miura","year":"2005","journal-title":"Atherosclerosis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/01.ATV.0000066134.79956.58","article-title":"High density lipoprotein-induced angiogenesis requires the activation of Ras\/MAP kinase in human coronary artery endothelial cells","volume":"23","author":"Miura","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5954757","DOI":"10.1155\/2021\/5954757","article-title":"Cilengitide inhibits neovascularization in a rabbit abdominal aortic plaque model by impairing the VEGF signaling","volume":"2021","author":"Zhu","year":"2021","journal-title":"Biomed Res Int"},{"key":"B90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"12","author":"Camar\u00e9","year":"2017","journal-title":"Redox Biol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1161\/01.ATV.0000178991.71605.18","article-title":"Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage","volume":"25","author":"Virmani","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s12033-021-00341-8","article-title":"Micro-RNA-338-3p promotes the development of atherosclerosis by targeting desmin and promoting proliferation","volume":"63","author":"Yan","year":"2021","journal-title":"Mol Biotechnol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"8668","DOI":"10.1002\/jcp.27527","article-title":"PINK1\/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMPK\u03b1 and exacerbates atherosclerotic lesions","volume":"234","author":"He","year":"2019","journal-title":"J Cell Physiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00018-010-0315-9","article-title":"TGF-\u03b2 stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2","volume":"67","author":"Burch","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/01.RES.0000126049.79800.CA","article-title":"Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migration","volume":"94","author":"Shimizu-Hirota","year":"2004","journal-title":"Circ Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"113775","DOI":"10.1016\/j.biopha.2022.113775","article-title":"Resveratrol inhibiting TGF\/ERK signaling pathway can improve atherosclerosis: backgrounds, mechanisms and effects","volume":"155","author":"Guo","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s11033-022-08225-z","article-title":"KAP1 modulates osteogenic differentiation via the ERK\/Runx2 cascade in vascular smooth muscle cells","volume":"50","author":"Bai","year":"2023","journal-title":"Mol Biol Rep"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1042\/BST20220271","article-title":"ERK1\/2 in immune signalling","volume":"50","author":"Lucas","year":"2022","journal-title":"Biochem Soc Trans"},{"key":"B99","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/01.RES.82.6.713","article-title":"Cell replication in the arterial wall: activation of signaling pathway following in vivo injury","volume":"82","author":"Koyama","year":"1998","journal-title":"Circ Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.cellsig.2007.03.002","article-title":"Vascular injury and modulation of MAPKs: a targeted approach to therapy of restenosis","volume":"19","author":"Yu","year":"2007","journal-title":"Cell Signal"},{"key":"B101","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/(SICI)1097-4652(199808)176:2%3C235::AID-JCP2%3E3.0.CO;2-P","article-title":"Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury","volume":"176","author":"Tanaka","year":"1998","journal-title":"J Cell Physiol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1161\/01.ATV.17.11.2808","article-title":"Activation of mitogen-activated protein kinases (ERK\/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury","volume":"17","author":"Hu","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jfma.2017.07.008","article-title":"TGF-\u03b21 stimulates cyclooxygenase-2 expression and PGE2 production of human dental pulp cells: role of ALK5\/Smad2 and MEK\/ERK signal transduction pathways","volume":"116","author":"Lin","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"B104","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and atherothrombosis","volume":"120","author":"D\u00f6ring","year":"2017","journal-title":"Circ Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2018.02.006","article-title":"The morphological and molecular mechanisms of epithelial\/endothelial-to-mesenchymal transition and its involvement in atherosclerosis","volume":"106","author":"Wesseling","year":"2018","journal-title":"Vasc Pharmacol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e26706","DOI":"10.1371\/journal.pone.0026706","article-title":"Mechanisms for vascular cell adhesion molecule-1 activation of ERK1\/2 during leukocyte transendothelial migration","volume":"6","author":"Abdala-Valencia","year":"2011","journal-title":"PLoS One"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J Mol Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.vph.2018.03.001","article-title":"Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis","volume":"114","author":"Aryal","year":"2019","journal-title":"Vasc Pharmacol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.7150\/thno.62797","article-title":"IRGM\/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: irgm1+\/-mice display increases atherosclerotic plaque stability","volume":"11","author":"Fang","year":"2021","journal-title":"Theranostics"},{"key":"B111","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/ATVBAHA.109.194902","article-title":"Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells","volume":"30","author":"Gessi","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.122.321431","article-title":"Fibroblast GSK-3alpha promotes fibrosis via RAF-MEK-ERK pathway in the injured heart","volume":"131","author":"Umbarkar","year":"2022","journal-title":"Circ Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3109\/13880209.2013.764328","article-title":"The effects of qindan-capsule-containing serum on the TGF-\u03b21\/ERK signaling pathway, matrix metalloproteinase synthesis and cell function in adventitial fibroblasts","volume":"51","author":"Yijing","year":"2013","journal-title":"Pharm Biol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"174200","DOI":"10.1016\/j.ejphar.2021.174200","article-title":"Corilagin ameliorates atherosclerosis by regulating MMP-1,-2, and-9 expression in vitro and in vivo","volume":"906","author":"Tao","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/01.CIR.103.5.670","article-title":"Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure","volume":"103","author":"Haq","year":"2001","journal-title":"Circulation"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/01.CIR.103.10.1453","article-title":"Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload","volume":"103","author":"Esposito","year":"2001","journal-title":"Circulation"},{"key":"B118","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B119","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijcard.2018.05.068","article-title":"Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy","volume":"270","author":"Mutlak","year":"2018","journal-title":"Int J Cardiol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jtbi.2010.04.023","article-title":"A multiscale model for eccentric and concentric cardiac growth through sarcomerogenesis","volume":"265","author":"Goktepe","year":"2010","journal-title":"J Theor Biol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","article-title":"Molecular pathways underlying cardiac remodeling during pathophysiological stimulation","volume":"122","author":"Kehat","year":"2010","journal-title":"Circulation"},{"key":"B122","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cardiores.2005.12.015","article-title":"Integrin signalling: the tug-of-war in heart hypertrophy","volume":"70","author":"Brancaccio","year":"2006","journal-title":"Cardiovasc Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.bbamem.2007.02.010","article-title":"Cardiac GPCRs: GPCR signaling in healthy and failing hearts","volume":"1768","author":"Salazar","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1073\/pnas.041604898","article-title":"Activation and targeting of extracellular signal-regulated kinases by \u03b2-arrestin scaffolds","volume":"98","author":"Luttrell","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B125","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by \u00df-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"key":"B126","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.3390\/ijms24054475","article-title":"Endothelin-1 induces cell proliferation and myofibroblast differentiation through the ET(A)R\/G(alphaq)\/ERK signaling pathway in human cardiac fibroblasts","volume":"24","author":"Duangrat","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B127","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.cellsig.2011.11.019","article-title":"CRP promotes MMP-10 expression via c-Raf\/MEK\/ERK and JAK1\/ERK pathways in cardiomyocytes","volume":"24","author":"Cui","year":"2012","journal-title":"Cell Signal"},{"key":"B128","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/01.ATV.0000060891.31516.24","article-title":"Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells","volume":"23","author":"Nagata","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2022.10.006","article-title":"Signaling network model of cardiomyocyte morphological changes in familial cardiomyopathy","volume":"174","author":"Khalilimeybodi","year":"2023","journal-title":"J Mol Cell Cardiol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jss.2009.11.132","article-title":"Increased phosphorylated extracellular signal-regulated kinase (ERK) in abdominal aortic aneurysms in a rodent model and in humans","volume":"158","author":"Ghosh","year":"2010","journal-title":"J Surg Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jamcollsurg.2012.06.414","article-title":"The role of extracellular signal-related kinase during abdominal aortic aneurysm formation","volume":"215","author":"Ghosh","year":"2012","journal-title":"J Am Coll Surg"},{"key":"B132","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGF\u03b2 signaling contributes to aortic aneurysm progression in Marfan syndrome mice","volume":"332","author":"Holm","year":"2011","journal-title":"Science"},{"key":"B133","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fcvm.2018.00124","article-title":"Medial hypoxia and adventitial vasa vasorum remodeling in human ascending aortic aneurysm","volume":"5","author":"Billaud","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1167\/iovs.01-1193","article-title":"Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis","volume":"44","author":"Bullard","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"11701","DOI":"10.3390\/ijms241411701","article-title":"Smooth muscle heterogeneity and plasticity in health and aortic aneurysmal disease","volume":"24","author":"Hu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/life12020191","article-title":"Abdominal aortic aneurysm formation with a focus on vascular smooth muscle cells","volume":"12","author":"Qian","year":"2022","journal-title":"Life (Basel)"},{"key":"B137","doi-asserted-by":"publisher","first-page":"35444","DOI":"10.1038\/srep35444","article-title":"Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1161\/ATVBAHA.119.312787","article-title":"Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation","volume":"39","author":"Petsophonsakul","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1111\/jcmm.14921","article-title":"Divergent effects of canonical and non-canonical TGF-\u03b2 signalling on mixed contractile-synthetic smooth muscle cell phenotype in human Marfan syndrome aortic root aneurysms","volume":"24","author":"Pedroza","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.trsl.2022.11.010","article-title":"Neutrophil extracellular traps induce abdominal aortic aneurysm formation by promoting the synthetic and proinflammatory smooth muscle cell phenotype via hippo-YAP pathway","volume":"255","author":"Yang","year":"2023","journal-title":"Transl Res J Lab Clin Med"},{"key":"B141","first-page":"511","article-title":"Smooth muscle cell phenotypic diversity between dissected and unaffected thoracic aortic media","volume":"54","author":"Zhang","year":"2013","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"B142","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.ATV.0000257552.94483.14","article-title":"Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms","volume":"27","author":"McCormick","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e010069","DOI":"10.1161\/JAHA.118.010069","article-title":"VPO1 modulates vascular smooth muscle cell phenotypic switch by activating extracellular signal-regulated kinase 1\/2 (ERK 1\/2) in abdominal aortic aneurysms","volume":"7","author":"Peng","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-9880.1000259","article-title":"Extracellular matrix remodelling and abdominal aortic aneurysm","volume":"4","author":"Basu","year":"2013","journal-title":"J Clin Exp Cardiol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1172\/JCI0215334","article-title":"Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms","volume":"110","author":"Longo","year":"2002","journal-title":"J Clin Invest"},{"key":"B146","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1196\/annals.1383.034","article-title":"Matrix metalloproteinase-2: the forgotten enzyme in aneurysm pathogenesis","volume":"1085","author":"Thompson","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B147","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12872-022-03012-x","article-title":"Hyperuricemia exacerbates abdominal aortic aneurysm formation through the URAT1\/ERK\/MMP-9 signaling pathway","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B148","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jss.2009.03.095","article-title":"Gender-dependent differential phosphorylation in the ERK signaling pathway is associated with increased MMP2 activity in rat aortic smooth muscle cells","volume":"160","author":"Ehrlichman","year":"2010","journal-title":"J Surg Res"},{"key":"B149","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-030-80614-9_7","article-title":"Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-\u03b2 signaling","volume":"1348","author":"Wheeler","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1172\/JCI130730","article-title":"Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome","volume":"130","author":"Bowen","year":"2020","journal-title":"J Clin Invest"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.1097\/01.hjh.0000501036.54612.96","article-title":"Os 36-07 treatment with apelin-13 prevents pressure overload-induced aortic adventitial remodeling and fibrosis in hypertensive rats with tac","volume":"34","author":"Zhong","year":"2016","journal-title":"J Hypertens"},{"key":"B152","doi-asserted-by":"publisher","first-page":"989933","DOI":"10.3389\/fimmu.2022.989933","article-title":"Immune and inflammatory mechanisms of abdominal aortic aneurysm","volume":"13","author":"M\u00e1rquez-S\u00e1nchez","year":"2022","journal-title":"Front Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"11078","DOI":"10.3390\/ijms231911078","article-title":"Role of extracellular matrix and inflammation in abdominal aortic aneurysm","volume":"23","author":"Stepien","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1155\/2009\/352319","article-title":"A systematic review of studies examining inflammation associated cytokines in human abdominal aortic aneurysm samples","volume":"26","author":"Golledge","year":"2009","journal-title":"Dis Markers"},{"key":"B156","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrcardio.2009.102","article-title":"Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation","volume":"6","author":"Hellenthal","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jcp.10435","article-title":"ERK1\/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the Ras dependent pathway","volume":"198","author":"Moon","year":"2004","journal-title":"J Cell Physiol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3390\/molecules22101551","article-title":"Current development status of MEK inhibitors","volume":"22","author":"Cheng","year":"2017","journal-title":"Molecules"},{"key":"B159","doi-asserted-by":"publisher","first-page":"27489","DOI":"10.1074\/jbc.270.46.27489","article-title":"PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo","volume":"270","author":"Alessi","year":"1995","journal-title":"J Biol Chem"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/nsmb859","article-title":"Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition","volume":"11","author":"Ohren","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"187ra69","DOI":"10.1126\/scitranslmed.3005066","article-title":"Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity","volume":"5","author":"Chintalgattu","year":"2013","journal-title":"Sci Transl Med"},{"key":"B162","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1002\/cncr.23460","article-title":"Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor","volume":"112","author":"Khakoo","year":"2008","journal-title":"Cancer"},{"key":"B163","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","author":"Kerkela","year":"2006","journal-title":"Nat Med"},{"key":"B164","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ejhf.58","article-title":"Ageing is a risk factor in imatinib mesylate cardiotoxicity","volume":"16","author":"Maharsy","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"B165","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41569-022-00717-6","article-title":"Repurposing drugs to treat cardiovascular disease in the era of precision medicine","volume":"19","author":"Abdelsayed","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B167","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/17460441.2020.1704729","article-title":"Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics","volume":"15","author":"Talevi","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"B168","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/ATVBAHA.114.305116","article-title":"Inhibition of ERK1\/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice","volume":"35","author":"Chen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1161\/01.CIR.0000147773.86866.CD","article-title":"Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase\/extracellular signal-regulated kinase inhibitor","volume":"110","author":"Gennaro","year":"2004","journal-title":"Circulation"},{"key":"B170","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajpath.2013.09.022","article-title":"Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation","volume":"184","author":"Stansfield","year":"2014","journal-title":"Am J Pathol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2016.02.017","article-title":"Cardiac concentric hypertrophy promoted by activated met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with pimasertib","volume":"93","author":"Sala","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e0159079","DOI":"10.1371\/journal.pone.0159079","article-title":"Selumetinib, an oral anti-neoplastic drug, may attenuate cardiac hypertrophy via targeting the ERK pathway","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"B173","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/01.HYP.0000062881.36813.7A","article-title":"Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats","volume":"41","author":"Sanada","year":"2003","journal-title":"Hypertension"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1 L613V mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J Clin Invest"},{"key":"B175","doi-asserted-by":"publisher","first-page":"107513","DOI":"10.1016\/j.isci.2023.107513","article-title":"Identifying shared transcriptional risk patterns between atherosclerosis and cancer","volume":"26","author":"Baylis","year":"2023","journal-title":"iScience"},{"key":"B176","doi-asserted-by":"publisher","first-page":"862","DOI":"10.4049\/jimmunol.1601059","article-title":"MEK1\/2 inhibition promotes macrophage reparative properties","volume":"198","author":"Long","year":"2017","journal-title":"J Immunol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"37895","DOI":"10.1074\/jbc.M007037200","article-title":"Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy","volume":"275","author":"Yue","year":"2000","journal-title":"J Biol Chem"},{"key":"B178","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/01.RES.0000041029.97988.E9","article-title":"Ras\/erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes","volume":"91","author":"Wang","year":"2002","journal-title":"Circ Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2016.02.017","article-title":"Cardiac concentric hypertrophy promoted by activated met receptor is mitigated in vivo by inhibition of Erk1, 2 signalling with pimasertib","volume":"93","author":"Sala","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J Clin Invest"},{"key":"B181","doi-asserted-by":"publisher","first-page":"121973","DOI":"10.1016\/j.lfs.2023.121973","article-title":"Tissue kallikrein-related peptidase8 accentuates cardiac fibrosis after myocardial ischemia-reperfusion injury via regulation of cardiac fibroblasts","volume":"329","author":"Song","year":"2023","journal-title":"Life Sci"},{"key":"B182","doi-asserted-by":"publisher","first-page":"e008543","DOI":"10.1161\/JAHA.118.008543","article-title":"Statins reduce thoracic aortic aneurysm growth in Marfan syndrome mice via inhibition of the Ras-induced ERK (extracellular signal-regulated kinase) signaling pathway","volume":"7","author":"Sato","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1161\/ATVBAHA.109.192609","article-title":"Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK","volume":"29","author":"Zhang","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"key":"B185","doi-asserted-by":"publisher","first-page":"e08648","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in marfan syndrome","volume":"4","author":"Doyle","year":"2015","journal-title":"Elife"},{"key":"B186","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000362997","article-title":"MCP-1 stimulates MMP-9 expression via ERK 1\/2 and p38 MAPK signaling pathways in human aortic smooth muscle cells","volume":"34","author":"Yang","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"B187","doi-asserted-by":"publisher","first-page":"104630","DOI":"10.1016\/j.ejmg.2022.104630","article-title":"Succesful MEK-inhibition of severe hypertrophic cardiomyopathy in RIT1-related Noonan syndrome","volume":"65","author":"Leegaard","year":"2022","journal-title":"Eur J Med Genet"},{"key":"B188","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic cardiomyopathy in Noonan syndrome treated by MEK-inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/genes13010006","article-title":"MEK inhibition in a newborn with RAF1-associated Noonan syndrome ameliorates hypertrophic cardiomyopathy but is insufficient to revert pulmonary vascular disease","volume":"13","author":"Mussa","year":"2021","journal-title":"Genes (Basel)"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jacc.2023.02.010","article-title":"MEK inhibition improves cardiomyopathy in Costello syndrome","volume":"81","author":"Geddes","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamadermatol.2018.4653","article-title":"Genotype-guided medical treatment of an arteriovenous malformation in a child","volume":"155","author":"Lekwuttikarn","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"e20193206","DOI":"10.1542\/peds.2019-3206","article-title":"Monitoring arteriovenous malformation response to genotype-targeted therapy","volume":"146","author":"Edwards","year":"2020","journal-title":"Pediatrics"},{"key":"B193","doi-asserted-by":"publisher","first-page":"e20200167","DOI":"10.1542\/peds.2020-0167","article-title":"Severe lymphatic disorder resolved with MEK inhibition in a patient with Noonan syndrome and SOS1 mutation","volume":"146","author":"Dori","year":"2020","journal-title":"Pediatrics"},{"key":"B194","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1200\/JGO.2015.000802","article-title":"Risk of selected cardiovascular toxicities in patients with cancer treated with MEK inhibitors: a comparative systematic review and meta-analysis","volume":"1","author":"Abdel-Rahman","year":"2015","journal-title":"J Glob Oncol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11912-022-01205-3","article-title":"Cardiac effects of BRAF and MEK inhibitors: mechanisms and clinical management","volume":"24","author":"Courand","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"B196","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jaccao.2023.09.006","article-title":"Cardiotoxicity of BRAF\/MEK inhibitors according to HFA\/ICOS cardiotoxicity risk category","volume":"5","author":"Courand","year":"2023","journal-title":"JACC CardioOncol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"102282","DOI":"10.1016\/j.ctrv.2021.102282","article-title":"Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors","volume":"100","author":"Arangalage","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"B198","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pharmthera.2018.06.017","article-title":"Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors","volume":"192","author":"Bronte","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B199","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B200","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/cncr.30435","article-title":"Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma","volume":"123","author":"Lim","year":"2017","journal-title":"Cancer"},{"key":"B201","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1158\/2159-8290.CD-20-0873","article-title":"Durable suppression of acquired MEK inhibitor resistance in cancer by sequestering MEK from ERK and promoting antitumor T-cell immunity","volume":"11","author":"Hong","year":"2021","journal-title":"Cancer Discov"},{"key":"B202","doi-asserted-by":"publisher","first-page":"102137","DOI":"10.1016\/j.ctrv.2020.102137","article-title":"MEK inhibitor resistance mechanisms and recent developments in combination trials","volume":"92","author":"Kun","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"B203","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc4000","article-title":"MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road","volume":"15","author":"Caunt","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B204","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","article-title":"Many ways to resistance: how melanoma cells evade targeted therapies","volume":"1871","author":"Kozar","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B205","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1158\/2159-8290.CD-13-0631","article-title":"MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF\/MEK inhibition","volume":"4","author":"Wagle","year":"2014","journal-title":"Cancer Discov"},{"key":"B206","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13046-019-1035-0","article-title":"Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR\/RAS\/MAPK pathway in KRAS-mutated human colorectal cancer cell lines","volume":"38","author":"Vitiello","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B207","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41389-018-0081-3","article-title":"Oncogenic PI3K\/AKT promotes the step-wise evolution of combination BRAF\/MEK inhibitor resistance in melanoma","volume":"7","author":"Irvine","year":"2018","journal-title":"Oncogenesis"},{"key":"B208","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1158\/1078-0432.CCR-13-0842","article-title":"Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma","volume":"19","author":"Bid","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B209","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ng.3218","article-title":"The hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies","volume":"47","author":"Lin","year":"2015","journal-title":"Nat Genet"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1404253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T05:02:47Z","timestamp":1719810167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1404253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":209,"alternative-id":["10.3389\/fcvm.2024.1404253"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1404253","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"article-number":"1404253"}}